Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors, antagonists |
Mechanism ACE inhibitors(Angiotensin-converting enzyme inhibitors), β-adrenoceptors antagonists(Beta adrenergic receptors antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H35NO8 |
InChIKeyRZPZLFIUFMNCLY-WLHGVMLRSA-N |
CAS Registry104344-23-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypertension | Phase 1 | Switzerland | - |